2023 annual financial data
Abivax 2023 Operating cash flow margin
Direct answer
Operating cash flow margin was -2,164.23%.
Operating income was -127,376,000 EUR and net income was -147,740,000 EUR.
Operating cash flow was -100,009,000 EUR.
Get free Abivax email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 4,621,000 EUR
- Operating income
- -127,376,000 EUR
- Net income
- -147,740,000 EUR
- Operating cash flow
- -100,009,000 EUR